Cross-Cultural Validation of the RECAP of Atopic Eczema Questionnaire in a Swedish Population
(2024) In Acta Dermato-Venereologica 104.- Abstract
A Swedish translation of the patient-reported outcome measure for assessing long-term control of atopic der-matitis, Recap of atopic eczema (RECAP), has not been validated. Cross-cultural translation and multi-centre validation of the translated RECAP questionnaire were therefore performed. Disease severity was assessed using the validated Investigator Global Assessment Scale for atopic dermatitis (vIGA-AD™). The Swedish RECAP was completed by 208 individuals aged 16 years or older with a median age of 36 years (inter-quartile range [IQR] 27–48). The participants consi-dered the questionnaire suitable for assessing eczema control. The median RECAP score (range 0–28) was 12 (IQR 5–19). The mean and median vIGA-AD™ scores (range 0–4) were... (More)
A Swedish translation of the patient-reported outcome measure for assessing long-term control of atopic der-matitis, Recap of atopic eczema (RECAP), has not been validated. Cross-cultural translation and multi-centre validation of the translated RECAP questionnaire were therefore performed. Disease severity was assessed using the validated Investigator Global Assessment Scale for atopic dermatitis (vIGA-AD™). The Swedish RECAP was completed by 208 individuals aged 16 years or older with a median age of 36 years (inter-quartile range [IQR] 27–48). The participants consi-dered the questionnaire suitable for assessing eczema control. The median RECAP score (range 0–28) was 12 (IQR 5–19). The mean and median vIGA-AD™ scores (range 0–4) were 2 (standard deviation [SD] 2) and 3 (IQR 2–4), respectively. A correlation between RECAP and the vIGA-AD™ was observed (p < 0.001). There was no significant change in scores for participants who answered the questionnaire twice within 14 days. Over time, improved or worsened eczema, as evaluated by vIGA-AD™, affected RECAP scores significantly (p < 0.001). The study suggests that RECAP can assess AD control in a Swedish clinical setting and shows acceptable reliability.
(Less)
- author
- organization
- publishing date
- 2024-06-19
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- atopic dermatitis, eczema, patient-reported outcome measure, validation study
- in
- Acta Dermato-Venereologica
- volume
- 104
- article number
- adv38889
- publisher
- Medical Journals Limited
- external identifiers
-
- pmid:38898676
- scopus:85196697694
- ISSN
- 0001-5555
- DOI
- 10.2340/actadv.v104.38889
- language
- English
- LU publication?
- yes
- id
- 3f227744-d5e1-4bb0-b40a-e7040085809b
- date added to LUP
- 2024-08-15 10:46:24
- date last changed
- 2024-08-16 03:04:06
@article{3f227744-d5e1-4bb0-b40a-e7040085809b, abstract = {{<p>A Swedish translation of the patient-reported outcome measure for assessing long-term control of atopic der-matitis, Recap of atopic eczema (RECAP), has not been validated. Cross-cultural translation and multi-centre validation of the translated RECAP questionnaire were therefore performed. Disease severity was assessed using the validated Investigator Global Assessment Scale for atopic dermatitis (vIGA-AD™). The Swedish RECAP was completed by 208 individuals aged 16 years or older with a median age of 36 years (inter-quartile range [IQR] 27–48). The participants consi-dered the questionnaire suitable for assessing eczema control. The median RECAP score (range 0–28) was 12 (IQR 5–19). The mean and median vIGA-AD™ scores (range 0–4) were 2 (standard deviation [SD] 2) and 3 (IQR 2–4), respectively. A correlation between RECAP and the vIGA-AD™ was observed (p < 0.001). There was no significant change in scores for participants who answered the questionnaire twice within 14 days. Over time, improved or worsened eczema, as evaluated by vIGA-AD™, affected RECAP scores significantly (p < 0.001). The study suggests that RECAP can assess AD control in a Swedish clinical setting and shows acceptable reliability.</p>}}, author = {{Sigurdardottir, Gunnthorunn and Alsterholm, Mikael and Anderson, Chris D. and Bradley, Maria and Sandström Falk, Marihelen and Johansson, Emma K. and Lundqvist, Maria and Sonesson, Andreas and Svensson, Åke and Theodosiou, Grigorios and Vrang, Sophie and Kobyletzki, Laura B.von}}, issn = {{0001-5555}}, keywords = {{atopic dermatitis; eczema; patient-reported outcome measure; validation study}}, language = {{eng}}, month = {{06}}, publisher = {{Medical Journals Limited}}, series = {{Acta Dermato-Venereologica}}, title = {{Cross-Cultural Validation of the RECAP of Atopic Eczema Questionnaire in a Swedish Population}}, url = {{http://dx.doi.org/10.2340/actadv.v104.38889}}, doi = {{10.2340/actadv.v104.38889}}, volume = {{104}}, year = {{2024}}, }